Sundquist, F;
Georgantzi, K;
Jarvis, KB;
Brok, J;
Koskenvuo, M;
Rascon, J;
van Noesel, M;
... Stenman, J; + view all
(2022)
A Phase II Trial of a Personalized, Dose-Intense Administration Schedule of 177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-Risk Neuroblastoma–LuDO-N.
Frontiers in Pediatrics
, 10
, Article 836230. 10.3389/fped.2022.836230.